SCUBE2 and neoplasm: Nevertheless, our studies to this point have shown that SCUBE2 acts a crucial VEGFR2 coreceptor during tumor angiogenesis, and targeting SCUBE2 on the cell surface may be an effective anti-angiogenic treatment strategy that may be especially useful in combination with cytotoxic chemotherapies.